C-N40UJuvena Therapeutics
secreted proteins, AI-enabled biologics, protein engineering
repairingbiologic
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-N40U
C-N40UC-N40Usecreted proteins, AI-enabled biologics, protein engineering
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Juvena Therapeutics secreted proteins, AI-enabled biologics, protein engineering
Juvena Therapeutics is a computationally driven biopharmaceutical company developing tissue restorative biologics for myopathies and metabolic diseases. Its platform mines proteins secreted by human stem cells, maps them to disease phenotypes, screens their ability to restore tissue homeostasis, and engineers them into biologic medicines. The company highlights a first-in-class myotonic dystrophy program and additional work in obesity, sarcopenia, lung, and liver diseases.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Juvena Therapeutics — Translational · Bottom quartile. Derived deterministically from 7 extracted project(s). Most-advanced status: phase 1. Band: translational. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic